Greg Mulholland – 2015 Parliamentary Question to the Department of Health

The below Parliamentary question was asked by Greg Mulholland on 2015-12-14.

To ask the Secretary of State for Health, what steps NHS England is taking to develop an in-year draft commissioning policy for the use of everolimus to treat tuberous sclerosis complex.

George Freeman

NHS England is currently developing a clinical commissioning policy statement to cover the use of Everolimus in adults with angiomyolipoma in association with tuberous sclerosis complex, as part of its in-year policy work programme.

In common with its standard process, NHS England has formed a policy working group and commissioned a clinical evidence review. This is now complete and is informing the development of a draft policy statement. The draft policy statement, along with the evidence review, will be shared and tested with stakeholders prior to formal consideration by NHS England in early 2016. The policy statement will be published in due course.

In the meantime, NHS England will continue to consider funding this treatment for individual patients in clinically exceptional and/or critically urgent clinical circumstances.